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Abstract 
BACKGROUND: Chronic Obstructive Pulmonary Disease (COPD) is a chronic inflammatory disease and 
disturbed bacterial clearance. Vitamin D deficiency is sometimes observed in COPD patients and as significant 
roles in increasing inflammation of airway obstruction and systemic obstruction, increasing pro-inflammatory 
cytokine including TNF-α, reduction of bacterial clearance and increase exacerbation risk due to infection. Also, 
vitamin D plays significant roles in the metabolism of calcium and mineralisation of bones and regulation system 
of immune. TNF-α also has essential roles in pathogenesis and inflammation of COPD. Several studies that 
investigate the relationship between vitamin D level and serum TNF-α concentration in COPD patients are 
relatively uncommon, including in Indonesia.  
AIM: This study aimed to assess the relationship between vitamin D level and TNF-α concentration in patients on 
the severity of the chronic obstructive pulmonary disease. 
METHODS: This study was a hospital-based descriptive cross-sectional study. Total samples were 50 COPD 
patients with the average age of older than 60 years during their enrollments at the Department of Pulmonology 
and Respiratory Medicine of the Dr Wahidin Sudirohusodo General Hospital Makassar in September 2018-
January 2019. All procedures of the present study were reviewed and approved by the Research Ethics 
Committee of Medicine Faculty of Hasanuddin University. The severity of COPD was assessed according to the 
combination of COPD assessment stages that referred to the Global Initiative for Chronic Obstructive Lung 
Disease (GOLD) Guideline 2015 that consisted of the combination of scoring COPD Assessment Test (CAT), the 
modified Medical Research Council (mMRC) questionnaire and results of the spirometry measurement. 
Assessment of airway obstruction levels referred to the GOLD spirometry criteria. Determination of thoracic 
photographs was conducted to verify the COPD diagnosis of the severity of COPD. Determination of serum TNF-
α concentration and vitamin D3 [1,25(OH)2D3] level used the ELISA method.  
RESULTS: The majority of COPD patients were observed in the category of older than 60 years old accounted for 
34 COPD patients (68%), and the majority of COPD patients were males accounted for 47 males with COPD 
(94%). The majority of COPD patients were observed in the group of D (38%). All the study subjects observed in 
this study were smokers, and 82% of them were in the category of heavy smokers. 21 study subjects had higher 
concentration of serum TNF-α (tertile 3 = 0.21-1.83 pg/dl), 20 study subjects and lower level of vitamin D (tertile 1 
= 182.1-364.5 pg/dl). The majority of the study subjects (38%) were in the category of severe COPD (category D 
of the severity of COPD at the tertile 3) according to the GOLD Combine Assessment. Given the relationship 
between vitamin D level and serum TNF-α concentration on the airway obstruction, there were significant positive 
correlations between the increase of vitamin D levels and the increase of serum TNF-α concentrations on airway 
obstruction. Given the relationship between vitamin D level and serum TNF-α concentration on the severity of 
COPD, there were significant positive correlations between the increase of vitamin D levels (tertiles 1, 2 and 3) 
and the increase of serum TNF-α concentrations on the severity of COPD at p-value < 0.05. Overall, there were 
non-linear relationships between vitamin D level and serum TNF-α concentration on the severity of COPD. 
CONCLUSIONS: Serum TNF-α concentration was positively associated with airway obstruction level and severity 
of COPD. Low level of vitamin D was negatively associated with airway obstruction level and severity of COPD. 
Vitamin D3 level (1,25(OH)2D) was negatively associated with serum TNF-α concentration and airway obstruction 
level and severity of COPD. 
 
Introduction 
 
Chronic Obstructive Pulmonary Disease 
(COPD) is a chronic inflammatory disease 
characterized by persistent airflow limitation of the 
lungs [1]
 
that includes a number of combinations of 
asthma bronchitis (spasms or involuntary contraction 
in the bronchial passages), emphysema (decreased 
elasticity of the alveoli) and chronic bronchitis 
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(inflammation of the bronchi) [2], [3]. The mechanistic 
basis underlying COPD is complex and can involve 
recurrent inflammation, oxidative stress (i.e., oxidant / 
antioxidant imbalance), protease/antiprotease 
imbalance, environmental insult, and host genetics [4]. 
Cigarette smoking is the primary 
environmental risk factor for COPD. Also, other 
environmental (e.g., wood smoke) and occupational 
exposures, as well as genetics, contribute to COPD 
pathogenesis. Consequently, pathologic changes and 
clinical symptoms are linked to the interaction of host 
factors with the environment. These interactions 
generate the pathologic triad of COPD: persistent 
inflammation, protease-antiprotease imbalance, and 
oxidative stress. This triad results in mucous/goblet 
cell metaplasia and hyperplasia, hyper mucus 
secretion, fibrosis, smooth-muscle alterations, and 
lung-tissue destruction. Chronic smoking exposes the 
respiratory tree and lungs to reactive oxygen species 
(ROS), resulting in oxidative stress and injury. This 
triggers the production of other ROS and lipid 
peroxidation and subsequent pulmonary inflammation 
[5], mainly due to infections by bacteria and viruses 
[5], [6]. Based on a population-based survey in nine 
Asia-Pacific territories in 2012, the overall estimated 
prevalence of COPD was 6.2%, ranging from 4.5% in 
Indonesia to 9.5% in Taiwan [7]. COPD is a significant 
cause of morbidity and mortality worldwide, and it is 
the sixth leading cause of death world [8]. The 
determinants of COPD pathogenesis are not a 
separate entity by itself where smoking tobacco is the 
primary environmental risk factor for COPD and other 
determinants of COPD-associated inflammation 
related with smoking tobacco that includes reactive 
oxygen species (ROS), protease-antiprotease 
imbalance and genetic variations or polymorphisms 
[5], respiratory viruses and bacteria which infect the 
lower airway and increase airway inflammation [6]. 
Low level of vitamin D is sometimes found in 
patients with COPD. High prevalence vitamin D 
deficiency in COPD patients is caused by the 
reduction of synthesis of vitamin D in skin due to 
ageing, poor diet, low capacity to store at fat related to 
wasting [9]. Some publications show the inconsistency 
results about the role of vitamin D and COPD [10]; 
some studies reported a correlation between vitamin 
D deficiency and pulmonary function. In the placebo-
controlled intervention study, Rafiq et al., [11] 
revealed that vitamin D had essential roles for the 
prevention of exacerbations (the increase of severity) 
in patients with COPD and vitamin D deficiency 
through vitamin D supplementation. Sank et al., [12]
 
proved the positive relationship between vitamin D 
deficiency and the severity of Chronic Obstructive 
Pulmonary Disease. 
Despite many mechanistic studies highlighting 
important anti-inﬂammatory and anti-infectious eﬀects 
of vitamin D in laboratory experiments, the clinical 
evidence in cohorts of patients with COPD remains 
contradictory. Several studies have shown that 
vitamin D could regulate activities of immune cells 
[13], restore respiratory muscle strength and 
inflammatory responses [14]. In COPD, there is a 
down-regulation of local signalling of vitamin D, 
leading to insufficient control of pro-inflammatory 
processes in airways [15]. COPD is associated with 
chronic inflammation affecting predominantly lung 
parenchyma and peripheral airways and results in 
mostly irreversible and progressive airflow limitation. 
This inflammation is characterised by increased 
numbers of alveolar macrophages, neutrophils, and T 
lymphocytes, which are recruited from the circulation. 
Oxidative stress plays a crucial role in driving this 
inflammation. Pulmonary inflammation may enhance 
the development and growth of lung cancer. The 
peripheral inflammation extends into the circulation, 
resulting in systemic inflammation with the same 
inflammatory proteins. Systemic inflammation may 
worsen comorbidities. Treatment of pulmonary 
inflammation may, therefore, have beneficial effects 
[16]. 
Multiple cytokines play roles in inflammatory 
airway diseases, such as COPD, through the 
recruitment, activation, and survival of inflammatory 
cells [17].
 
This is proven from the increase of TNF-α 
concentration according to the examination of induced 
sputum and lung biopsy of COPD patients [18].
 
TNF-α 
is the most extensively studied cytokine in patients 
with COPD, and it is a potent activator of NF-κβ and 
amplifies the inflammatory response. TNF-α plays a 
significant role in many inflammatory diseases 
affecting the lung, such as chronic bronchitis (CB), 
COPD, asthma, acute lung injury (ALI) and acute 
respiratory distress syndrome (ARDS) [19].
 
However, 
studies that investigate the relationship between 
vitamin D level and serum TNF-α concentration in 
COPD patients are relatively uncommon, including in 
Indonesia. For that reason, this study aimed to assess 
the relationship between vitamin D level and TNF-α 
concentration in patients on the severity of the chronic 
obstructive pulmonary disease. 
 
 
Methods  
 
This study was a hospital-based descriptive 
cross-sectional study. Total samples were 50 COPD 
patients with the average age of older than 60 years 
during their enrollments at the Department of 
Pulmonology and Respiratory Medicine of the Dr 
Wahidin Sudirohusodo General Hospital Makassar in 
September 2018-January 2019. All procedures of the 
present study were reviewed and approved by the 
Research Ethics Committee of Medicine Faculty of 
Hasanuddin University as stated in the 
Recommendation Letter of Research Ethics issued in 
the registration No.1052/H.4.8.4.5.31/PP36-
KOMETIK/2018. 
Clinical Science 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
2300                                                                                                                                                                                              https://www.id-press.eu/mjms/index 
 
Inclusion criteria include COPD patients with 
dyspnea (difficulty in breathing) and chronic cough 
with sputum. There was a history of exposure of 
cigarette fog and other irritants, results of diagnosis 
using the spirometry test at FEV1/FVC < 70% and 
post-bronchodilator (after the use of certain drugs to 
reduces the tone of smooth muscle in the lungs’ 
bronchioles to increase their diameter) at FEV1 < 80%. 
The severity of COPD was assessed according to the 
combination of COPD assessment stages that 
referred to the Global Initiative for Chronic Obstructive 
Lung Disease (GOLD) Guideline 2015 that consisted 
of the combination of scoring COPD Assessment Test 
(CAT), the modified Medical Research Council 
(mMRC) questionnaire and results of the spirometry 
measurement. Assessment of airway obstruction 
levels referred to the GOLD spirometry criteria. 
Determination of thoracic photographs was conducted 
to verify no other respiratory diseases except COPD. 
Determination of serum TNF-α concentration and 
vitamin D3 [1,25(OH)2D3] level used the ELISA 
method (Thermo Scientific Multiscan FC). Exclusion 
criteria include individuals with asthma, lung 
tuberculosis, bronchiectasis (dilatation of the bronchi) 
and patients with COPD in the category of acute 
exacerbation and the use of oral steroids. 
 
Statistical analysis 
The study data were processed and analysed 
using the Statistical Package for Social Science 
(SPSS) version 22. The analytical method used in this 
study was descriptive statistics using frequency 
distribution, whereas the statistical test used in this 
study was Kolmogorov-Smirnov’s test used to 
determine the normality of data. Chi-square test was 
used to assess the strength of the correlation or 
relationship between two categorical variables. 
Kruskal-Wallis test was used to compare mean values 
of numerical data based on the categorical variables 
of more than two correlated variables. Results of 
statistical tests were significant when p-value < 0.05. 
Results of data analyses were presented in the form 
tables and graphs along with their descriptions. 
 
 
 
Results 
 
A total number of study subjects were 50 
COPD patients who fulfilled the inclusion criteria. The 
majority of COPD patients were observed in the 
category of older than 60 years old accounted for 34 
COPD patients (68%), and the majority of COPD 
patients were males considered for 47 males with 
COPD (94%). The study subjects were statistically 
distributed. The majority of COPD patients were 
observed in group D (38%). Vitamin D levels were 
classified into 3 tertiles, and the most significant 
frequency of COPD patients was seen at the tertile 1 
of vitamin D level accounted for 20 COPD patients 
(40%). Serum TNF-α concentrations were also 
classified into three tertiles, and the most considerable 
frequency of COPD patients was noticed at the tertile 
3 of serum TNF-α level accounted for 21 COPD 
patients (42%). Baseline characteristics of the study 
subjects are shown in Table 1. 
Table 1: Baseline characteristics of the study subjects with 
COPD 
Variable n % 
Gender Male 
Female 
47 
3 
94.0 
6.0 
Age 40-59 years old 
≥ 60 years old 
16 
34 
32.0 
68.0 
Smoking status Mild 
Moderate 
Severe 
1 
8 
41 
2.0 
16.0 
82.0 
Serum TNF-α 
concentration
a
 
Tertile 1 
Tertile 2 
Tertile 3 
12 
17 
21 
24.0 
34.0 
42.0 
Vitamin D Level
b 
Tertile 1 
Tertile 2 
Tertile 3 
20 
15 
15 
40.0 
30.0 
30.0 
Severity of COPD A 
B 
C 
D 
5 
18 
8 
19 
10.0 
36.0 
16.0 
38.0 
a 
Tertile 1 (0. 00-0.06 pg/dl); Tertile 2 (0.07-0.20 pg/dl); Tertil 3 (0.21-1.83 pg/dl); 
b 
Tertile 1 
(182. 1-364.5 pg/mL); Tertile 2 (364.7-630.7 pg/mL); Tertile 3 (632.6-3707.2 pg/mL). 
 
TNF-α concentrations at the tertile 1 were 
dominant for COPD patients in the groups A and B 
(24%). TNF-α levels at the tertile 2 were prevailing for 
COPD patients in the groups B and C (34%) whereas 
TNF-α levels were dominant at the tertile 3 for COPD 
patients in the group D (42%). 
Table 2: Frequency distribution of severity of COPD according 
to TNF-α level 
Serum TNF-α Level 
Severity of COPD Total 
A B C D 
 
Tertile 1 
n 3 9 0 0 12 
% 25.0% 75.0% 0.0% 0.0% 100.0% 
Tertile 2 
n 2 9 6 0 17 
% 11.8% 52.9% 35.3% 0.0% 100.0% 
Tertile 3 
n 0 0 2 19 21 
% 0.0% 0.0% 9.5% 90.5% 100.0% 
Total 
n 5 18 8 19 50 
% 10.0% 36.0% 16.0% 38.0% 100.0% 
 
 
Relationship between vitamin D level and 
 serum TNF-α concentration on the airway 
 obstruction 
Table 3 shows the statistical correlations of 
vitamin D level and serum TNF-α concentration on 
airway obstruction. There were significant positive 
correlations between the increase of vitamin D levels 
and the increase of serum TNF-α concentrations on 
airway obstruction according to the rise of GOLD 
values (p < 0.05) at the tertile 1 of vitamin D levels 
with the highest concentration of serum TNF-α at the 
tertile 1 was 0.24 pg/dl. There were also significant 
positive correlations between the increase of vitamin 
D levels and the increase of serum TNF-α 
concentrations on airway obstruction according to the 
rise in GOLD values (p < 0.05) at the tertile 2 of 
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vitamin D levels with the highest concentration of 
serum TNF-α at the tertile 2 was 0.93 pg/dl. In 
addition, there were positive significant correlations 
between the increase of vitamin D levels and the 
increase of serum TNF-α concentrations on airway 
obstruction according to the rise in GOLD values (p < 
0.05) at the tertile 3 of vitamin D levels with the 
highest concentration of serum TNF-α at the tertile 3 
was 0.48 pg/dl. 
Table 3: Statistical correlations of vitamin D level and TNF-α 
concentration on airway obstruction 
Vitamin D Airway Obstruction n Mean TNF-α SD p 
Tertile 1 
Mild 
Moderate 
Severe 
Very severe 
3 
11 
5 
1 
0.04 
0.06 
0.24 
0.23 
0.02 
0.05 
0.19 
- 
0.024 
Tertile 2 
Mild 
Moderate 
Severe 
Very severe 
1 
4 
6 
4 
0.04 
0.04 
0.22 
0.93 
- 
0.05 
0.15 
0.63 
0.012 
Tertile 3 
Moderate 
Severe 
Very severe 
4 
4 
7 
0.12 
0.31 
0.48 
0.04 
0.11 
0.24 
0.018 
 
 
Data in Table 3 also illustrate the relationship 
between serum TNF-α concentration and airway 
obstruction level. There was a positive significant 
linear correlation between vitamin D level and serum 
TNF-α concentration on the airway obstruction level 
with the correlation coefficient value = 0.502 at p-
value = 0.000, and the most considerable airway 
obstruction was observed at the tertile 3.  
Correlation pattern of vitamin D and TNF-α on 
the airway obstruction level airway was not linear, and 
the highest TNF-α concentration with vitamin D level 
was observed at the tertile 2 (Figure 1). 
  
Figure 1: Linear relationship between vitamin D level and serum 
TNF-α concentration with the severity of airway obstruction 
 
Relationship between vitamin D level and 
serum TNF-α concentration on the severity of COPD 
On the whole, there were positive significant 
correlations between the increase of vitamin D levels 
(tertiles 1, 2 and 3) and the increase of serum TNF-α 
concentrations on the severity of COPD at p-value < 
0.05 although the rise in serum TNF-α concentrations 
was not linear with the rise of vitamin D levels with the 
largest concentration of TNF-α was observed at the 
tertile 2 of vitamin D levels (Table 4). 
Table 4: Statistical correlation between vitamin D level and 
serum TNF-α concentration with the severity of COPD 
Vitamin D Level Severity of COPD n Mean TNF-α SD p 
Tertile 1 
A 
B 
C 
D 
2 
12 
3 
3 
0.04 
0.06 
0.15 
0.33 
0.02 
0.05 
0.12 
0.17 
0.021 
Tertile 2 
A 
B 
C 
D 
2 
3 
3 
7 
0.06 
0.03 
0.10 
0.68 
0.03 
0.05 
0.03 
0.55 
0.008 
Tertile 3 
A 
B 
C 
D 
1 
3 
2 
9 
0.07 
0.14 
0.24 
0.46 
- 
0.03 
0.14 
0.22 
0.025 
 
Overall, there were non-linear relationships 
between vitamin D level and serum TNF-α 
concentration on the severity of COPD (Figure 2). 
 
Figure 2: Non-linear relationships between vitamin D level and 
serum TNF-α concentration on the severity of COPD 
 
 
Discussion 
 
Characteristics of the study subjects  
A total of the study subjects identified in this 
study were50 patients according to the history of the 
disease, clinical descriptions, and spirometry test. Of 
50 study subjects, the majority of them were male 
accounted for 47 patients (94%) and 3 females (6%), 
and the majority of the study subjects are in the 
category of age older than 60 years old. Results of 
this study are consistent with those of the case-control 
study conducted by Sanket et al., for 81 COPD 
patients that consisted of 75 males (92.5%) [12].
 
The 
higher prevalence rate of COPD for the male group is 
associated with a higher prevalence rate of smokers 
for males compared to females [20].
 
All the study 
subjects observed in this study were smokers, and 
82% of them were in the category of heavy smokers. 
Twenty-One study subjects had higher concentration 
of serum TNF-α (tertile 3 = 0.21-1.83 pg/dl), 20 study 
subjects and lower level of vitamin D (tertile 1 = 182.1-
364.5 pg/dl). The majority of the study subjects (38%) 
Tertile 3 
Clinical Science 
_______________________________________________________________________________________________________________________________ 
 
_______________________________________________________________________________________________________________________________ 
2302                                                                                                                                                                                              https://www.id-press.eu/mjms/index 
 
were in the category of severe COPD (category D of 
the severity of COPD at the tertile 3) according to the 
GOLD Combine Assessment. 
 
Distribution of severity of COPD according 
 to serum TNF-α concentration 
As shown in Table 2, 12 study subjects were 
classified into two categories (A and B) according to 
the severity of COPD. The lowest TNF-α level was 
observed at the tertile 1 (= 0.00-0.06 ng/dl) accounted 
for, 17 study subjects are seen at the tertile 2 (0.07-
0.20 pg/dl) and the tertile 3 with 21 study subjects. 
With refers to the analysis of above data distribution, 
mild COPD had the lowest serum TNF-α 
concentration whereas patients with high severe 
COPD and highest TNF-α level. These results 
coincide with those of the study of Maharaj et al., [21] 
that serum TNF-α concentration was positively 
associated with airway obstruction level and severity 
of COPD. 
All the study subjects in this study are 
smokers, and 82% are heavy smokers. This coincides 
with the research of Watanabe et al., [22]
 
for 142 non-
COPD subjects that serum TNF-α concentrations of 
smokers increased compared to non-smokers and 
hypothesized that light smoking was associated with 
an increase in WBC counts, while heavy smoking was 
responsible for TNF-α activation in Japanese male 
subjects with standard glucose tolerance and the 
study of Tanni et al., [23]
 
pertaining to the association 
between inflammation, smoking status, and disease 
and showed that serum TNF-α was higher in COPD 
current smokers [4.8 (4.2-5.8) pg/mL] and in current 
smoker controls [4.8 (4.2-6.1) pg/mL] when compared 
to COPD ex-smokers [4.3 (3.9-4.9) pg/mL; p = 0.02] 
and to never-smoker controls [3.7 (3.4-4.0) pg/mL; p < 
0.001] and concluded smoking may influence TNF-α 
mediated systemic inflammation, which, in turn, may 
account for some of the benefits observed in patients 
with COPD who stop smoking. In view of the 
association between TNF-α concentration and 
severity COPD, results of this study are coherent with 
those of the research performed by Healing V et al., 
[24]
 
that spontaneous TNF-α production was 5.0 times 
higher in patients with severe COPD compared to 
mild-to-moderate COPD (p = 0.02), and serum TNF-α 
was significantly elevated in patients versus controls 
(2.1 ±0.3 vs 1.1 ±0.1) at p = 0.007 and concluded that 
increasing airflow obstruction and hypercapnia was 
associated with an enhanced TNF-α response in 
COPD.A meta-analysis study conducted by Wei
 
et al., 
[25] revealed that patients with stable COPD had 
higher serum IL-6 concentrations than healthy 
controls. No evidence showing a positive or negative 
association between IL-6 concentrations and the 
severity of pulmonary function impairment was found. 
The correlation between IL-6 levels and pulmonary 
function was weak in different severities of stable 
COPD patients. 
Low level of vitamin D is sometimes found in 
patients with COPD. High prevalence of vitamin D 
deficiency in COPD patients is caused by the 
reduction of synthesis of vitamin D in skin due to 
ageing, poor diet, low capacity to store at fat related to 
wasting [9]. Active metabolism of vitamin D3 
(1,25(OH)2D3) increase the expression of an 
antimicrobial peptide, and reduce the expression of 
pro-inflammatory cytokines and can be used to 
explain the relationship between vitamin D and 
susceptibility of respiratory infection. Vitamin D 
deficiency also affects pulmonary function through 
various mechanisms, innate and adaptive immunity 
systems in the pathogenesis of COPD [27]. 
Overall, vitamin D level assessed in this study 
was not significantly associated with serum TNF-α 
concentration on airway obstruction level and severity 
of COPD. Various unobserved factors influencing 
vitamin D level and serum TNF-α concentration were 
not assessed in this study including physical activity, 
lifestyle, and nutritional status of the study subjects as 
investigated in the study of Bouillon et al., [28]. 
Moreover, levels of 1,25(OH)2D3 serum are also 
affected by serum Vitamin D Binding Protein (VDBP) 
level, phosphorus serum, parathyroid hormone [30]. In 
contrary, results of this study are consistent with those 
of the study Mekovet al., [31]
 
(2015) and of the study 
Nishimura et al., [32]
 
(2016) that there was not a 
significant positive correlation between vitamin D level 
and severity of COPD. 
Results of this study were not consistent with 
the study of Sanket et al., [12] that COPD was 
associated with the risk increase of vitamin D 
deficiency, and there was a significant association 
between level vitamin D and severity of COPD. Zhu et 
al., (2015) [33] investigated the association between 
host serum 25-hydroxyvitamin D (25(OH)D) and the 
susceptibility and severity of COPD and found that low 
serum levels of 25(OH)D were not associated with 
COPD susceptibility, but the high deficiency rate of 
25(OH)D was associated with COPD severity. Vitamin 
D supplementation may prevent COPD exacerbation. 
Vitamin D supplements could prevent COPD 
exacerbation as shown by Rafiq et al., (2015) [11] that 
a low level of vitamin D was positively associated with 
the severity of COPD. 
This study has some limitations that did not 
evaluate other determinants influencing vitamin D3 
status including lifestyles, eating behaviours, 
medications, serum vitamin D binding protein (VDBP), 
and serum vitamin D2 (25OHD). All information in this 
descriptive cross-sectional study was collected at the 
same time, and the study subjects were contacted 
only once. The temporal sequence of cause and effect 
could not be addressed in this study in assessing 
temporal relationships of vitamin D3 level, cytokine 
response, worsening of symptoms and severity of 
COPD, but it might be suggestive of an association 
that should be investigated more fully by further 
studies. 
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In conclusion, serum TNF-α concentration 
was positively associated with airway obstruction level 
and severity of COPD. Low level of vitamin D was 
negatively associated with airway obstruction level 
and severity of COPD. Vitamin D3 level {1,25(OH)2D} 
was negatively associated with serum TNF-α 
concentration and airway obstruction level and 
severity of COPD. 
Further studies are necessary for determining 
more cytokines involved in pathogenesis and severity 
of COPD as well as search for determinants 
influencing vitamin D3 level to elucidate a more 
authentic relationship between the two pathological 
findings.  
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